Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)
Clinical trial NCT05549284 · UNKNOWN
Trial details
- NCT number
- NCT05549284
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-05-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.